China Healthwise Holdings Ltd is an investment holding company mainly engaged in the Chinese health products business. The Company operates its business through three segments. The Chinese Health Products segment is mainly engaged in the sale of Chinese health products business. The Money Lending Business segment is mainly engaged in the granting loans business. The Investment in Financial Instruments segment is mainly engaged in investing in financial instruments.

Employees

Sector

Pharmaceuticals

More about the company

Market Closed - Hong Kong S.E. 11:08:32 18/09/2026 +03			5-day change	1st Jan Change
0.0730 ^HKD	-1.35%		-.--%	-46.32%

09-18	Hwa Sheng International Investment Limited entered into the Sale and Purchase Agreement to acquire 20.30% stake in China Healthwise Holdings Limited from Eternity Finance Group Limited and Lei Hong Wai for HKD 15 million.	CI
09-18	Eternity Investment Unit, Director Dispose Of Stake in China Healthwise	MT

Market Cap	67.49M 8.6M 7.68M 7.06M 6.41M 12.04M 815M 12.34M 84.26M 33.9M 430M 32.29M 31.6M 1.36B	P/E 2024	-2.96x	P/E 2025	-40.2x
Enterprise Value	107M 13.7M 12.24M 11.24M 10.21M 19.17M 1.3B 19.65M 134M 53.97M 685M 51.41M 50.31M 2.17B	EV / Sales 2024	1.54x	EV / Sales 2025	1.45x
Free-Float	63.03%	Yield 2024 *	-	Yield 2025	-

09-18	Hwa Sheng International Investment Limited entered into the Sale and Purchase Agreement to acquire 20.30% stake in China Healthwise Holdings Limited from Eternity Finance Group Limited and Lei Hong Wai for HKD 15 million.	CI
09-18	Eternity Investment Unit, Director Dispose Of Stake in China Healthwise	MT
08-27	China Healthwise Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	China Healthwise Raises HK$10.8 Million from Share Issue	MT
08-25	China Healthwise Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2026	CI
05-12	China Healthwise Holdings says Future Empire disposes of 3.4 million Huanxi shares for HK$853,000 on May 12	RE
05-12	China Healthwise Unit Sells Shares in Huanxi Media	MT
04-29	China Healthwise Holdings Limited Auditor Raises 'Going Concern' Doubt	CI
04-13	China Healthwise Trims Yunfeng Stake with Nearly HK$2 Million Sale	MT
04-10	China Healthwise says Future Empire disposed of 500,000 shares in Yunfeng for HK$1.6 mln on Apr 10	RE
03-27	China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-25	China Healthwise Expects Loss to Narrow Up to 96% in 2025; Shares Rise 11%	MT
03-24	China Healthwise expects FY loss attributable of HK$1.8 million-HK$3.4 million	RE

03/08/21	Monthly Return of Equity Issuer on Movements in Securities: Month ended 31 July 2021	PU
03/05/21	Monthly Return of Equity Issuer on Movements in Securities : Month ended 30 April 2021	PU
21/04/21	FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 24 JUNE 2021 AT 11:15 A.M. (OR AT ANY ADJOURNMENT THEREOF)	PU
21/04/21	China Healthwise : PROPOSALS FOR RE-ELECTION OF RETIRING DIRECTORS; GRANTING OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	PU
01/04/21	Monthly Return of Equity Issuer on Movements in Securities : Month ended 31 March 2021	PU

China Healthwise Holdings Limited Stock

Stocks

348

KYG2120E1290

Pharmaceuticals

Valuation: China Healthwise Holdings Limited

Chart: China Healthwise Holdings Limited

Latest news: China Healthwise Holdings Limited

Press Releases: China Healthwise Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors: China Healthwise Holdings Limited

Latest insider transactions

Pharmaceuticals Wholesale

Financials

Company Profile

Current year	0.05	0.19
1 year	0.05	0.22
3 years	0.03	0.22
5 years	0.03	0.32
10 years	0.03	2.6

Director	Title	Age	Since
Hong Wai Lei CHM	Chairman	57	11/10/2016
Hok Lim Lai BRD	Director/Board Member	67	27/10/2016
Chin Pang Tsang BRD	Director/Board Member	47	01/07/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CHINA HEALTHWISE HOLDINGS LIMITED	-1.35%	-.--%	-54.38%	+35.19%	8.6M
ELI LILLY AND COMPANY	-0.11%	+9.94%	+57.20%	+148.21%	1,257B
JOHNSON & JOHNSON	-1.62%	-0.95%	+42.90%	+75.88%	651B
ABBVIE INC.	-0.98%	-0.14%	+34.93%	+102.23%	510B
ROCHE HOLDING AG	-1.56%	-1.39%	+51.02%	+64.18%	388B
MERCK & CO., INC.	-2.49%	+2.01%	+75.38%	+39.94%	366B
NOVARTIS AG	-0.02%	+3.15%	+32.47%	+55.33%	303B
ASTRAZENECA PLC	-0.72%	+7.05%	+10.34%	+32.79%	288B
AMGEN INC.	-0.90%	+2.97%	+55.67%	+70.93%	252B
GILEAD SCIENCES, INC.	-1.68%	+5.27%	+37.21%	+105.26%	211B
Average	-1.10%	+4.56%	+34.28%	+72.99%	422.67B
Weighted average by Cap.	-0.73%	+5.30%	+47.25%	+93.14%

	2024	2025
Net sales	114M 14.47M 12.93M 11.88M 10.79M 20.26M 1.37B 20.77M 142M 57.04M 724M 54.33M 53.17M 2.29B	99.56M 12.69M 11.34M 10.41M 9.46M 17.76M 1.2B 18.21M 124M 50M 634M 47.63M 46.61M 2.01B
Net income	-40.28M -5.13M -4.59M -4.21M -3.83M -7.19M -486M -7.37M -50.29M -20.23M -257M -19.27M -18.86M -814M	-2.61M -332K -297K -273K -248K -465K -31.46M -477K -3.25M -1.31M -16.61M -1.25M -1.22M -52.63M
Net Debt	55.59M 7.08M 6.33M 5.81M 5.28M 9.92M 671M 10.16M 69.4M 27.92M 354M 26.59M 26.02M 1.12B	39.98M 5.09M 4.55M 4.18M 3.8M 7.13M 483M 7.31M 49.91M 20.08M 255M 19.12M 18.71M 807M